Duarte, CANCT03523975Now EnrollingIRB Ready

Mantle Cell Lymphoma Clinical Trial in Duarte, CA

Access cutting-edge mantle cell lymphoma treatment through this phase 1/2 clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.

Sponsored by City of Hope Medical Center

Quick Self-Assessment

See if you qualify for this Duarte location

Preparing your pre-screening questions…

Expert Care in Duarte

Access mantle cell lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mantle cell lymphoma treatment provided free

Apply for This Duarte Location

Check if you qualify for this mantle cell lymphoma clinical trial in Duarte, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Duarte

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Duarte site if eligible
  4. 4Begin participation

About This Mantle Cell Lymphoma Study in Duarte

The purpose of this study is to determine if giving an experimental drug called venetoclax in combination with lenalidomide and rituximab is safe and effective for treating people with Mantle Cell Lymphoma (MCL).

Sponsor: City of Hope Medical Center

Who Can Participate

Inclusion Criteria

Age ≥18 years
Diagnosis of mantle cell lymphoma (MCL) established by histologic assessment
Laboratory, radiographic, physical exam findings and/or symptoms attributable to MCL
ECOG Performance Status (Eastern Cooperative Oncology Group Performance Status: an attempt to quantify cancer patients' general well-being and activities of daily life. The score ranges from 0 to 5 where 0 is asymptomatic and 5 is death) less or equal to 2
All study participants must be registered into the mandatory Revlimid REMS® program, and be willing and able to comply with the requirements of the REMS® program
Females of reproductive potential must adhere to the scheduled pregnancy testing as required in the Revlimid REMS® program.
Men and Women of childbearing potential on appropriate contraception
Adequate organ function
Ability to understand and the willingness to sign a written informed consent.
Ability to swallow oral capsules/tablets

Exclusion Criteria

Prior treatment for MCL with chemotherapy
Pregnant or breastfeeding women
Grade 2 or higher peripheral neuropathy
Known history of CNS (Central Nervous System) or leptomeningeal by MCL prior to study enrollment
Significant cardiovascular disease
Any condition that might significantly impair drug absorption as determined by the investigator
Uncontrolled active systemic fungal, bacterial, viral, or other infection, or intravenous anti-infective treatment within 2 weeks before first dose of study drug
History of stroke or intracranial hemorrhage within 6 months of 1st dose of study drug
Concurrent participation in another clinical trial
Subject has received a moderate or strong CYP3A inhibitor or inducer within 1 week prior to treatment initiation.
Psychiatric illness or social situations that would limit compliance with study requirements
Subject has known positivity to HIV
Active infection with Hepatitis B or C virus as determined by a detectable viral load on PCR.
Prior malignancy except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or any other cancer from which the subject has been disease free for ≥ 2 years or which will not limit survival to\< 2 years.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Duarte?

Yes, this clinical trial (NCT03523975) has an active research site in Duarte, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mantle Cell Lymphoma Treatment Options in Duarte, CA

If you're searching for mantle cell lymphoma treatment options in Duarte, CA, this clinical trial (NCT03523975) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Duarte research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced mantle cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mantle cell lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Duarte, CA

See all lymphoma clinical trials recruiting in Duarte — not just this study.

Browse Lymphoma Trials in Duarte →

Browse More Trials by Condition

Lymphoma TrialsMantle Cell Lymphoma TrialsPulmonary Hypertension TrialsTemporal Lobe Epilepsy TrialsAll Conditions →

Ready to Join in Duarte?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Duarte, CA